trisequens has been researched along with Atypical Endometrial Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coelingh Bennink, HJ; Dören, M; Holzgreve, W; Rübig, A | 1 |
| Gräser, T; Koytchev, R; Müller, A; Oettel, M | 1 |
2 trial(s) available for trisequens and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
Topics: Aged; Anabolic Agents; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endosonography; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Incidence; Middle Aged; Norethindrone; Norpregnenes; Prospective Studies; Tablets; Uterine Hemorrhage; Vagina | 1999 |
Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
Topics: Biopsy; Breast Diseases; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrium; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Nandrolone; Norethindrone; Postmenopause; Prospective Studies; Therapeutic Equivalency; Treatment Outcome; Uterine Hemorrhage | 2000 |